Drug Firm Pays Billions for Misbranding Antipsychotics

Johnson & Johnson was sued for failing to report data suggesting increased risks for stroke and diabetes associated with the antipsychotic Risperdal.

Read More >> Drug Firm Pays Billions for Misbranding Antipsychotics